Sampath Padmavathi

Associate Director, Process Development at KaliVir Immunotherapeutics

Sampath Padmavathi has worked in the field of research for over two decades. Sampath began their career in 1996 as a Research Associate at CLRI. In 2001, they joined the University of Pittsburgh as a Research Associate and later became a Research Instructor in 2017. That same year, they moved to Western Oncolytics as a Scientist and was promoted to Senior Scientist in 2019. In 2020, they joined KaliVir Immunotherapeutics as a Senior Scientist.

Sampath Padmavathi is currently enrolled at the University of Pittsburgh.

Location

Pittsburgh, United States

Links


Org chart

No direct reports

Teams


Offices


KaliVir Immunotherapeutics

KaliVir Immunotherapeutics was founded in 2019 to pioneer a unique and novel approach to cancer treatment that engages a virus’ natural ability to replicate in and kill cancer cells


Industries

Employees

51-200

Links